These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 36039829)
1. Clinical presentation and outcomes of hospitalized children with COVID-19 in Mexico City. Diaz DR; Urrutia S; Gutierrez G; Cuevas F Pediatr Pulmonol; 2022 Dec; 57(12):3044-3049. PubMed ID: 36039829 [TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area. Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712 [TBL] [Abstract][Full Text] [Related]
3. Clinical and epidemiological characteristics of children with SARS-CoV-2 infection: a case series in Sinaloa. Pérez-Gaxiola G; Flores-Rocha R; Valadez-Vidarte JC; Hernández-Alcaraz M; Herrera-Mendoza G; Real-Lugo MÁD Bol Med Hosp Infant Mex; 2021; 78(1):18-23. PubMed ID: 33661874 [TBL] [Abstract][Full Text] [Related]
4. Clinical and Epidemiological Characteristics of Paediatric Patients Diagnosed with COVID-19 in a Tertiary Hospital in Mexico City. Macias-Parra M; Fortes-Gutierrez S; Aguilar-Gomez N; Diaz-Garcia L; Otero-Mendoza F; Arias de la Garza E; Ordoñez-Ortega J; Palacios-Reyes D; Diaz-Jimenez IV; Serrano-Sierra A; Xochihua-Díaz L; Saltigeral-Simental P J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 34213541 [TBL] [Abstract][Full Text] [Related]
5. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. Richardson S; Hirsch JS; Narasimhan M; Crawford JM; McGinn T; Davidson KW; ; Barnaby DP; Becker LB; Chelico JD; Cohen SL; Cookingham J; Coppa K; Diefenbach MA; Dominello AJ; Duer-Hefele J; Falzon L; Gitlin J; Hajizadeh N; Harvin TG; Hirschwerk DA; Kim EJ; Kozel ZM; Marrast LM; Mogavero JN; Osorio GA; Qiu M; Zanos TP JAMA; 2020 May; 323(20):2052-2059. PubMed ID: 32320003 [TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York. Zachariah P; Johnson CL; Halabi KC; Ahn D; Sen AI; Fischer A; Banker SL; Giordano M; Manice CS; Diamond R; Sewell TB; Schweickert AJ; Babineau JR; Carter RC; Fenster DB; Orange JS; McCann TA; Kernie SG; Saiman L; JAMA Pediatr; 2020 Oct; 174(10):e202430. PubMed ID: 32492092 [TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory characteristics of children with SARS-CoV-2 infection. Berksoy E; Kanik A; Çiçek A; Bardak Ş; Elibol P; Demir G; Yilmaz N; Nalbant T; Gökalp G; Yilmaz Çiftdoğan D Pediatr Pulmonol; 2021 Dec; 56(12):3674-3681. PubMed ID: 34516721 [TBL] [Abstract][Full Text] [Related]
9. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up. Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547 [TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City. Chao JY; Derespina KR; Herold BC; Goldman DL; Aldrich M; Weingarten J; Ushay HM; Cabana MD; Medar SS J Pediatr; 2020 Aug; 223():14-19.e2. PubMed ID: 32407719 [TBL] [Abstract][Full Text] [Related]
14. Severe Coronavirus Disease Pneumonia in Pediatric Patients in a Referral Hospital. Ozcan S; Emeksiz S; Perk O; Uyar E; Kanik Yüksek S J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 34081145 [TBL] [Abstract][Full Text] [Related]
15. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
16. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study. Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796 [TBL] [Abstract][Full Text] [Related]
19. Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers. Khoury R; Bernstein PS; Debolt C; Stone J; Sutton DM; Simpson LL; Limaye MA; Roman AS; Fazzari M; Penfield CA; Ferrara L; Lambert C; Nathan L; Wright R; Bianco A; Wagner B; Goffman D; Gyamfi-Bannerman C; Schweizer WE; Avila K; Khaksari B; Proehl M; Heitor F; Monro J; Keefe DL; D'Alton ME; Brodman M; Makhija SK; Dolan SM Obstet Gynecol; 2020 Aug; 136(2):273-282. PubMed ID: 32555034 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status. Du H; Dong X; Zhang JJ; Cao YY; Akdis M; Huang PQ; Chen HW; Li Y; Liu GH; Akdis CA; Lu XX; Gao YD Allergy; 2021 Feb; 76(2):510-532. PubMed ID: 32524611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]